Primary progressive multiple sclerosis to be treated with ocrelizumab: a mistaken case of cobalamin deficiency | BMJ Case Reports

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Learning from errors

CASE REPORT

Primary progressive multiple sclerosis to be treated with ocrelizumab: a mistaken case of cobalamin deficiency

Online download statistics by month:

Online download statistics by month: May 2019 to January 2022

	Abstract	Full	Pdf
May 2019	851	23	30
Jun 2019	1145	29	19
Jul 2019	551	10	4
Aug 2019	357	1	0
Sep 2019	367	4	5
Oct 2019	66	5	3
Nov 2019	94	2	0
Dec 2019	87	2	2
Jan 2020	79	14	5
Feb 2020	70	5	3
Mar 2020	50	7	2
Apr 2020	62	0	1
May 2020	82	1	0
Jun 2020	106	3	2
Jul 2020	54	3	0
Aug 2020	59	1	1
Sep 2020	77	0	3
Oct 2020	81	3	4
Nov 2020	60	0	0
Dec 2020	77	5	2
Jan 2021	144	1	0
Feb 2021	79	1	0
Mar 2021	82	2	1
Apr 2021	98	4	0
May 2021	27	0	1
Jun 2021	6	0	1
Jul 2021	3	2	0
Aug 2021	6	3	0
Sep 2021	1	1	1
Oct 2021	50	1	1
Nov 2021	76	0	0
Dec 2021	32	0	0
Jan 2022	19	1	0
Total	4998	134	91